This website is supported by an unrestricted educational grant provided by sanofi-aventis US LLC. Sanofi-aventis does not control operational aspects of this website, regularly review its content, nor monitor this site for the reporting of adverse events.

To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088, or http://www.fda.gov/. Suspected adverse reactions that involve sanofi-aventis products can be reported to sanofi-aventis U.S. LLC at 1-800-633-1610 or to the FDA.

Browse by Tags

All Tags » barriers to advancing therapy » type 2 diabetes (RSS)
Barriers to Advancing Treatment With Insulin Therapy for Type 2 Diabetes Mellitus Patients
A significant challenge facing primary care physicians (PCPs) in the treatment of their patients with type 2 diabetes mellitus (T2DM) is overcoming patient and clinical barriers that prevent advancing treatment with insulin therapy. As discussed in Dr...
Posted: Jan 17 2008, 05:41 PM by CommunityOfBestPractices | with 5 comment(s)
Filed under: , ,